ABSTRACT
Lung transplantation is commonly used for patients with end-stage lung disease. However,
there is continuing debate on the optimal operation for patients with chronic obstructive
pulmonary disease (COPD) and pulmonary fibrosis. Single-lung transplantation (SLT)
provides equivalent short- and medium-term results compared with bilateral lung transplantation
(BLT), but long-term survival appears slightly better in BLT recipients (especially
in patients with COPD). The number of available organs for lung transplantation also
influences the choice of operation. Recent developments suggest that the organ donor
shortage is not as severe as previously thought, making BLT a possible alternative
for more patients. Local expertise and waiting list issues are important in influencing
the choice of SLT versus BLT. Most of the data support the use of BLT for the majority
of COPD patients when available, and the use of SLT for the majority of idiopathic
pulmonary fibrosis (IPF) patients. The ultimate choice of operation will depend on
donor and recipient characteristics and local expertise and waiting list issues.
KEYWORDS
Lung transplantation - chronic obstructive pulmonary disease - idiopathic pulmonary
fibrosis
REFERENCES
- 1
Trulock E P, Edwards L B, Taylor D O, Boucek M M, Keck B M, Hertz M I.
Registry of the International Society for Heart and Lung Transplantation: twenty-second
official adult lung and heart-lung transplant report-2005.
J Heart Lung Transplant.
2005;
24
956-967
- 2
Pierson III R N, Barr M L, McCullough K P et al..
Thoracic organ transplantation.
Am J Transplant.
2004;
4(Suppl 9)
93-105
- 3
Meyers B F, Lynch J P, Trulock E P, Guthrie T, Cooper J D, Patterson G A.
Single versus bilateral lung transplantation for idiopathic pulmonary fibrosis: a
ten-year institutional experience.
J Thorac Cardiovasc Surg.
2000;
120
99-107
- 4
Pochettino A, Kotloff R M, Rosengard B R et al..
Bilateral versus single lung transplantation for chronic obstructive pulmonary disease:
intermediate-term results.
Ann Thorac Surg.
2000;
70
1813-1818
discussion 1818-1819
- 5
Sundaresan R S, Shiraishi Y, Trulock E P et al..
Single or bilateral lung transplantation for emphysema?.
J Thorac Cardiovasc Surg.
1996;
112
1485-1494
discussion 1494-1495
- 6
Meyer D M, Edwards L B, Torres F, Jessen M E, Novick R J.
Impact of recipient age and procedure type on survival after lung transplantation
for pulmonary fibrosis.
Ann Thorac Surg.
2005;
79
950-957
discussion 957-958
- 7
Hadjiliadis D, Chaparro C, Messier R H et al..
Impact of lung transplant operation on bronchiolitis obliterans syndrome (BOS) in
patients with idiopathic pulmonary fibrosis (IPF) [abstract].
Am J Transplant.
2003;
5S
A695
- 8
Whelan T PM, Dunitz J M, Kelly R F et al..
Effect of preoperative pulmonary artery pressure on early survival after lung transplantation
for idiopathic pulmonary fibrosis.
J Heart Lung Transplant.
2005;
24
1269-1274
- 9
Palmer S M, Davis R D, Simsir S A et al..
Successful bilateral lung transplant outcomes in recipients 61 years of age and older.
Transplantation.
2006;
81
862-865
- 10
Hosenpud J D, Bennett L E, Keck B M, Edwards E B, Novick R J.
Effect of diagnosis on survival benefit of lung transplantation for end-stage lung
disease.
Lancet.
1998;
351
24-27
- 11
De Meester J, Smits J M, Persijn G G, Haverich A.
Listing for lung transplantation: life expectancy and transplant effect, stratified
by type of end-stage lung disease, the Eurotransplant experience.
J Heart Lung Transplant.
2001;
20
518-524
- 12
Charman S C, Sharples L D, McNeil K D, Wallwork J.
Assessment of survival benefit after lung transplantation by patient diagnosis.
J Heart Lung Transplant.
2002;
21
226-232
- 13
Meyer D M, Bennett L E, Novick R J, Hosenpud J D.
Single vs bilateral, sequential lung transplantation for end-stage emphysema: influence
of recipient age on survival and secondary end-points.
J Heart Lung Transplant.
2001;
20
935-941
- 14
Cassivi S D, Meyers B F, Battafarano R J et al..
Thirteen-year experience in lung transplantation for emphysema.
Ann Thorac Surg.
2002;
74
1663-1669
discussion 1669-1670
- 15
Hadjiliadis D, Chaparro C, Gutierrez C et al..
Impact of lung transplant operation on bronchiolitis obliterans syndrome in patients
with chronic obstructive pulmonary disease.
Am J Transplant.
2006;
6
183-189
- 16
Weill D, Torres F, Hodges T N, Olmos J J, Zamora M R.
Acute native lung hyperinflation is not associated with poor outcomes after single
lung transplant for emphysema.
J Heart Lung Transplant.
1999;
18
1080-1087
- 17
Malchow S C, McAdams H P, Palmer S M, Tapson V F, Putman C E.
Does hyperexpansion of the native lung adversely affect outcome after single lung
transplantation for emphysema? Preliminary findings.
Acad Radiol.
1998;
5
688-693
- 18
Venuta F, Boehler A, Rendina E A et al..
Complications in the native lung after single lung transplantation.
Eur J Cardiothorac Surg.
1999;
16
54-58
- 19
Moy M L, Loring S H, Ingenito E P, Mentzer S J, Reilly Jr J J.
Causes of allograft dysfunction after single lung transplantation for emphysema: extrinsic
restriction versus intrinsic obstruction. Brigham and Women's Hospital Lung Transplantation
Group.
J Heart Lung Transplant.
1999;
18
986-993
- 20
Mal H, Brugiere O, Sleiman C et al..
Morbidity and mortality related to the native lung in single lung transplantation
for emphysema.
J Heart Lung Transplant.
2000;
19
220-223
- 21
McAdams H P, Erasmus J J, Palmer S M.
Complications (excluding hyperinflation) involving the native lung after single-lung
transplantation: incidence, radiologic features, and clinical importance.
Radiology.
2001;
218
233-241
- 22
Collins J, Kazerooni E A, Lacomis J et al..
Bronchogenic carcinoma after lung transplantation: frequency, clinical characteristics,
and imaging findings.
Radiology.
2002;
224
131-138
- 23
Barr M L, Kawut S M, Whelan T P et al..
Report of the ISHLT working group on primary lung graft dysfunction, IV: Recipient-related
risk factors and markers.
J Heart Lung Transplant.
2005;
24
1468-1482
- 24
Anyanwu A C, McGuire A, Rogers C A, Murday A J.
Assessment of quality of life in lung transplantation using a simple generic tool.
Thorax.
2001;
56
218-222
- 25
Gerbase M W, Spiliopoulos A, Rochat T, Archinard M, Nicod L P.
Health-related quality of life following single or bilateral lung transplantation:
a 7-year comparison to functional outcome.
Chest.
2005;
128
1371-1378
- 26 National Data on Lung Transplantation .United Network of Organ Sharing. Data reports. Available at http://www.unos.org Accessed July 20th, 2006
- 27 Organ distribution: allocation of thoracic organs. United Network of Organ Sharing. Available at http://www.unos.org Accessed July 20th, 2006
- 28 National Data on Lung Transplantation .United Network of Organ Sharing. Data reports. Available at http://www.unos.org Accessed June 16th, 2006
- 29
Hadjiliadis D, Ahya V N, Christie J D, Sager J S, Pocchettino A, Kotloff R M.
Early results of lung transplantation after implementation of the new lung allocation
score.
J Heart Lung Transplant.
2006;
25
1167-1170
- 30
Angel L F, Levine D J, Restrepo M I et al..
Impact of a lung transplantation donor-management protocol on lung donation and recipient
outcomes.
Am J Respir Crit Care Med.
2006;
, online early June 23, 2006 as doi: 10.1164/rccm.200603-432OC
- 31
Bhorade S M, Vigneswaran W, McCabe M A, Garrity E R.
Liberalization of donor criteria may expand the donor pool without adverse consequence
in lung transplantation.
J Heart Lung Transplant.
2000;
19
1199-1204
- 32
Pierre A F, Sekine Y, Hutcheon M A, Waddell T K, Keshavjee S H.
Marginal donor lungs: a reassessment.
J Thorac Cardiovasc Surg.
2002;
123
421-427
discussion 427-428
Denis HadjiliadisM.D. M.H.S. F.R.C.P.(C) F.C.C.P.
University of Pennsylvania, Hospital of the University of Pennsylvania
835 W. Gates Bldg., 3400 Spruce St., Philadelphia, PA 19104
Email: Denis.Hadjiliadis@uphs.upenn.edu